{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-9897"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-9897","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Effect of Hyperoxia on Type-1 Diabetic Mouse Model","abstract":"Administration of Hyperoxia (>90 % oxygen) is a pervasive intervention to supplement respiratory needs in patients admitted in ICU/critical care units. Current literature suggests that prolonged use of Hyperoxia therapy is directly associated with in-hospital mortality. The exact reason for this high mortality under Hyperoxia is unknown. Recent explorations in Dr. Panguluri lab identified that dysregulation of Kv channels plays a vital role in the pathophysiology of Hyperoxia-induced pulmonary and cardiac complications using animal models. The proposed research will focus on the part of Hyperoxia in generating cardiotoxicity and ventricular remodeling in the type-1 diabetes patients using the Akita, mouse model.","abstract_html":"Administration of Hyperoxia (&gt;90 % oxygen) is a pervasive intervention to supplement respiratory needs in patients admitted in ICU/critical care units. Current literature suggests that prolonged use of Hyperoxia therapy is directly associated with in-hospital mortality. The exact reason for this high mortality under Hyperoxia is unknown. Recent explorations in Dr. Panguluri lab identified that dysregulation of Kv channels plays a vital role in the pathophysiology of Hyperoxia-induced pulmonary and cardiac complications using animal models. The proposed research will focus on the part of Hyperoxia in generating cardiotoxicity and ventricular remodeling in the type-1 diabetes patients using the Akita, mouse model.","abstract_has_math":false,"creators":["Bolleddu, Samuel Ignatious"],"institution":"University of South Florida","degree_name":null,"degree_level":"Thesis","degree_discipline":"College of Pharmacy","degree_department":null,"school":null,"contributors":["Siva Kumar Panguluri, Ph.D.","Manas Biswal, Ph.D.","Jennifer Rodgers, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019-06-18T07:00:00Z","date_published":"2019-06-18T07:00:00Z","updated_at":"2026-11-19T08:45:24Z","subjects":["Hospital mortality","Kv channels","Cardiotoxicity","Ventricular remodeling","Medicine and Health Sciences","Pharmacy and Pharmaceutical Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/8702","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/8702","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-9897","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Siva Kumar Panguluri, Ph.D.","Manas Biswal, Ph.D.","Jennifer Rodgers, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Bolleddu, Samuel Ignatious"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2019-06-18T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["College of Pharmacy"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis","M.S."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Hospital mortality","Kv channels","Cardiotoxicity","Ventricular remodeling","Medicine and Health Sciences","Pharmacy and Pharmaceutical Sciences"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights.license","label":"Dc Rights License","values":["default"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/8702"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Administration of Hyperoxia (>90 % oxygen) is a pervasive intervention to supplement respiratory needs in patients admitted in ICU/critical care units. Current literature suggests that prolonged use of Hyperoxia therapy is directly associated with in-hospital mortality. The exact reason for this high mortality under Hyperoxia is unknown. Recent explorations in Dr. Panguluri lab identified that dysregulation of Kv channels plays a vital role in the pathophysiology of Hyperoxia-induced pulmonary and cardiac complications using animal models. The proposed research will focus on the part of Hyperoxia in generating cardiotoxicity and ventricular remodeling in the type-1 diabetes patients using the Akita, mouse model."]},{"key":"dc:title","label":"Title","values":["Effect of Hyperoxia on Type-1 Diabetic Mouse Model"]}]}],"canonical_facts":{"dc:contributor":["Siva Kumar Panguluri, Ph.D.","Manas Biswal, Ph.D.","Jennifer Rodgers, Ph.D."],"dc:creator":["Bolleddu, Samuel Ignatious"],"dc:date":["2019-06-18T07:00:00Z"],"dc:description":["Administration of Hyperoxia (>90 % oxygen) is a pervasive intervention to supplement respiratory needs in patients admitted in ICU/critical care units. Current literature suggests that prolonged use of Hyperoxia therapy is directly associated with in-hospital mortality. The exact reason for this high mortality under Hyperoxia is unknown. Recent explorations in Dr. Panguluri lab identified that dysregulation of Kv channels plays a vital role in the pathophysiology of Hyperoxia-induced pulmonary and cardiac complications using animal models. The proposed research will focus on the part of Hyperoxia in generating cardiotoxicity and ventricular remodeling in the type-1 diabetes patients using the Akita, mouse model."],"dc:identifier":["https://digitalcommons.usf.edu/etd/8702"],"dc:rights.license":["default"],"dc:subject":["Hospital mortality","Kv channels","Cardiotoxicity","Ventricular remodeling","Medicine and Health Sciences","Pharmacy and Pharmaceutical Sciences"],"dc:title":["Effect of Hyperoxia on Type-1 Diabetic Mouse Model"],"thesis:degree_discipline":["College of Pharmacy"],"thesis:degree_level":["Thesis","M.S."],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:45:24Z"}